RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+8.52%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.35B
AUM Growth
+$1.35B
(+13%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
27.72%
Holding
140
New
11
Increased
64
Reduced
5
Closed
4
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$22.1M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$11.3M |
| 3 |
Cigna
CI
|
$10.9M |
| 4 |
Clearside Biomedical
CLSD
|
$9.49M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$8.45M |
Top Sells
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$32.7M |
| 2 |
Elevance Health
ELV
|
$16.8M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$9.49M |
| 4 |
Cooper Companies
COO
|
$7.33M |
| 5 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$5.82M |
Sector Composition
| 1 | Healthcare | 78.14% |
| 2 | Financials | 3.99% |
| 3 | Industrials | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thermo Fisher Scientific
TMO
$183B
| $14.8M | 1.1% |
100,200
| – | – |
|
27
McKesson
MCK
$85.9B
| $14.5M | 1.08% |
77,900
+400
| +0.5% | +$74.7K |
|
28
Bristol-Myers Squibb
BMY
$96.7B
| $14.5M | 1.07% |
196,500
+26,500
| +16% | +$1.95M |
|
29
Penumbra
PEN
$10.5B
| $14.4M | 1.07% |
242,500
+14,000
| +6% | +$833K |
|
30
Jazz Pharmaceuticals
JAZZ
$7.99B
| $14.4M | 1.07% |
102,000
+16,500
| +19% | +$2.33M |
|
31
Collegium Pharmaceutical
COLL
$1.25B
| $14.4M | 1.07% |
1,215,000
+70,000
| +6% | +$830K |
|
32
Amgen
AMGN
$153B
| $14.3M | 1.06% |
94,000
| – | – |
|
33
Pediatrix Medical
MD
$1.45B
| $14.1M | 1.05% |
195,000
| – | – |
|
34
Biogen
BIIB
$20.8B
| $13.9M | 1.03% |
57,650
+4,500
| +8% | +$1.09M |
|
35
TherapeuticsMD
TXMD
$12.7M
| $13.4M | 0.99% |
1,575,000
| – | – |
|
|
WBA
36
DELISTED
Walgreens Boots Alliance
WBA
| $13.4M | 0.99% |
160,400
+36,900
| +30% | +$3.07M |
|
37
Incyte
INCY
$17B
| $12.4M | 0.92% |
155,000
+24,500
| +19% | +$1.96M |
|
38
Galapagos
GLPG
$2.06B
| $11.6M | 0.86% |
210,000
| – | – |
|
39
Ardelyx
ARDX
$1.57B
| $11.1M | 0.82% |
1,275,000
+214,600
| +20% | +$1.87M |
|
40
Prothena Corp
PRTA
$452M
| $10.8M | 0.8% |
308,000
| – | – |
|
|
PRAH
41
DELISTED
PRA Health Sciences, Inc.
PRAH
| $10.6M | 0.78% |
253,000
| – | – |
|
|
DERM
42
DELISTED
Dermira, Inc.
DERM
| $10.4M | 0.77% |
354,900
+64,900
| +22% | +$1.9M |
|
43
Encompass Health
EHC
$12.5B
| $10.3M | 0.76% |
265,000
+57,000
| +27% | +$2.21M |
|
|
ACHN
44
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $10.2M | 0.76% |
1,312,500
+92,500
| +8% | +$722K |
|
|
WMGI
45
DELISTED
Wright Medical Group Inc
WMGI
| $9.52M | 0.7% |
547,900
+57,900
| +12% | +$1.01M |
|
|
46
Clearside Biomedical
CLSD
$26.7M
| $9.49M | 0.7% |
+1,353,326
| New | +$9.49M |
|
47
Travere Therapeutics
TVTX
$1.75B
| $9.29M | 0.69% |
521,400
| – | – |
|
48
BioMarin Pharmaceuticals
BMRN
$11.3B
| $8.79M | 0.65% |
113,000
+9,750
| +9% | +$759K |
|
|
XNPT
49
DELISTED
XENOPORT, INC.
XNPT
| $8.41M | 0.62% |
1,195,000
+95,000
| +9% | +$669K |
|
50
Alkermes
ALKS
$4.95B
| $8.41M | 0.62% |
194,500
| – | – |
|